We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
What's new
This page lists items that we have published for the first time or updated in the last 7, 30 or 60 days. Use the filters to narrow results by audience, product type, content type or topic.
You can also stay informed by:
- subscribing to our updates to receive same-day notification emails on safety information, scheduling updates or media releases.
- checking our consultation hub.
- joining any upcoming events.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (18)
- Clinical trials (2)
- Committees and advisory bodies (5)
- Compliance and enforcement (28)
- Cosmetics (2)
- COVID-19 (2)
- Fees and payments (4)
- Import and export (13)
- Labelling and packaging (7)
- Legislation (3)
- Manufacturing (18)
- Medicinal cannabis hub (4)
- Safety monitoring and information (21)
- Scheduling (national classification system) (5)
- Shortages and supply disruptions (15)
- Sunscreens (6)
- Unique Device Identification (UDI) hub (26)
- Vaping hub (1)
- Weight loss products (3)
What's new
191 result(s) found, displaying 151 to 175
-
CommitteeInformation on the terms of reference, membership, and meetings of the Regulatory and Technical Consultative Forum for Medical Devices (RegTech Forum)
-
-
User guideLearn how to access the AusUDID Production and Pre-Production environments.
-
-
PageUnderstand the roles in the AusUDID and what each role can do.
-
PageLearn about the different ways you can submit UDI records to the AusUDID.
-
PageFind solutions to common issues when accessing or submitting UDI records to the AusUDID.
-
PageLearn best practice tips to help you create accurate, complete and compliant UDI records.
-
Australian public assessment report (AusPar)Blenrep approved for the treatment of relapsed or refractory multiple myeloma in combination with bortezomib and dexamethasone in patients who have received prior therapy and in combination with pomalidomide and dexamethasone.
-
PageView published decisions relating to the granting of licences for the manufacture of therapeutic goods in Australia.
-
Medicine shortage alertsThe acute national shortages of IV fluids have resolved.
-
PageThis page explains how to search for Australian manufacturers licensed to manufacture medicines, blood and biologicals, and where to find details of licensing decisions made by us in relation to Australian manufacturers.
-
User guideLearn how to manage UDI records when a device is supplied by more than one sponsor.
-
PageView published decisions relating to the revocation of licences for the manufacture therapeutic goods in Australia.
-
User guideLearn how to search, view and download UDI records in the AusUDID.
-
PageLearn how to electronically submit UDI records using GS1’s National Product Catalogue (NPC).
-
User guideLearn how to prepare and submit up to 200 UDI records at once using the Australian UDI Bulk Upload Template.
-
User guideLearn how to create and manage UDI records in the AusUDID online portal.
-
PageThe page provides consumers with up-to-date information on current issues relating to sunscreens, including SPF testing. It’s important that Australians continue to use sunscreens to protect against the harmful effects of UV radiation.
-
PageThis page provides sponsors with up-to-date information on current issues relating to sunscreens, including SPF testing.
-
PageView published decisions relating to the suspension of licences for the manufacture of therapeutic goods in Australia.
-
PageUnderstand key concepts that apply to creating and managing UDI records in the AusUDID.
-
Regulatory decision noticesThe Therapeutic Goods Administration (TGA) has published decisions relating to manufacturing licences for therapeutic goods.
-
PageThe shortages of most methylphenidate modified-release products have resolved.
-
PageRead about court actions. It is our practice to publish details of regulatory compliance decisions and actions on our website.